Kagami Ogata syndrome : a small deletion refines critical region for imprinting
© 2024. The Author(s)..
Kagami-Ogata syndrome is a rare imprinting disorder and its phenotypic overlap with multiple different etiologies hampers diagnosis. Genetic etiologies include paternal uniparental isodisomy (upd(14)pat), maternal allele deletions of differentially methylated regions (DMR) in 14q32.2 or pure primary epimutations. We report a patient with Kagami-Ogata syndrome and an atypical diagnostic odyssey with several negative standard-of-care genetic tests followed by epigenetic testing using methylation microarray and a targeted analysis of whole-genome sequencing to reveal a 203 bp deletion involving the MEG3 transcript and MEG3:TSS-DMR. Long-read sequencing enabled the simultaneous detection of the deletion, phasing, and biallelic hypermethylation of the MEG3:TSS-DMR region in a single assay. This case highlights the challenges in the sequential genetic testing paradigm, the utility of long-read sequencing as a single comprehensive diagnostic assay, and the smallest reported deletion causing Kagami-Ogata syndrome allowing important insights into the mechanism of imprinting effects at this locus.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
NPJ genomic medicine - 9(2024), 1 vom: 11. Jan., Seite 5 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kilich, Gonench [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 10.02.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1038/s41525-023-00389-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367028603 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367028603 | ||
| 003 | DE-627 | ||
| 005 | 20240210233115.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41525-023-00389-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1287.xml |
| 035 | |a (DE-627)NLM367028603 | ||
| 035 | |a (NLM)38212313 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kilich, Gonench |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Kagami Ogata syndrome |b a small deletion refines critical region for imprinting |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 10.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a Kagami-Ogata syndrome is a rare imprinting disorder and its phenotypic overlap with multiple different etiologies hampers diagnosis. Genetic etiologies include paternal uniparental isodisomy (upd(14)pat), maternal allele deletions of differentially methylated regions (DMR) in 14q32.2 or pure primary epimutations. We report a patient with Kagami-Ogata syndrome and an atypical diagnostic odyssey with several negative standard-of-care genetic tests followed by epigenetic testing using methylation microarray and a targeted analysis of whole-genome sequencing to reveal a 203 bp deletion involving the MEG3 transcript and MEG3:TSS-DMR. Long-read sequencing enabled the simultaneous detection of the deletion, phasing, and biallelic hypermethylation of the MEG3:TSS-DMR region in a single assay. This case highlights the challenges in the sequential genetic testing paradigm, the utility of long-read sequencing as a single comprehensive diagnostic assay, and the smallest reported deletion causing Kagami-Ogata syndrome allowing important insights into the mechanism of imprinting effects at this locus | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Hassey, Kelly |e verfasserin |4 aut | |
| 700 | 1 | |a Behrens, Edward M |e verfasserin |4 aut | |
| 700 | 1 | |a Falk, Marni |e verfasserin |4 aut | |
| 700 | 1 | |a Vanderver, Adeline |e verfasserin |4 aut | |
| 700 | 1 | |a Rader, Daniel J |e verfasserin |4 aut | |
| 700 | 1 | |a Cahill, Patrick J |e verfasserin |4 aut | |
| 700 | 1 | |a Raper, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Zhe |e verfasserin |4 aut | |
| 700 | 1 | |a Westerfer, Dawn |e verfasserin |4 aut | |
| 700 | 1 | |a Jadhav, Tanaya |e verfasserin |4 aut | |
| 700 | 1 | |a Conlin, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Izumi, Kosuke |e verfasserin |4 aut | |
| 700 | 1 | |a Rajagopalan, Ramakrishnan |e verfasserin |4 aut | |
| 700 | 1 | |a Sullivan, Kathleen E |e verfasserin |4 aut | |
| 700 | 0 | |a UDN Consortium |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t NPJ genomic medicine |d 2016 |g 9(2024), 1 vom: 11. Jan., Seite 5 |w (DE-627)NLM262254506 |x 2056-7944 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2024 |g number:1 |g day:11 |g month:01 |g pages:5 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41525-023-00389-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2024 |e 1 |b 11 |c 01 |h 5 | ||